ESMO® 2026 Highlights: Presenter Vignettes – Zev Wainberg

Dr. Zev Wainberg

Zev Wainberg

MD

UCLA Health

LBA82

Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Additional subgroup analyses from the Ph3 RASolute 302 study.